Clinical Trials on 可切除癌 in Germany
总计1494个结果
-
University Hospital HeidelbergGerman Cancer Research Center; Heidelberg University主动,不招人
-
University Hospital HeidelbergGerman Cancer Research Center; Heidelberg University完全的
-
German Breast GroupCelgene Corporation; Amgen完全的炎性乳腺癌 | HER2阳性乳腺癌 | 管状乳腺癌 II 期 | 粘液性乳腺癌 II 期 | 乳腺癌女性 NOS | 浸润性导管癌 | 管状乳腺癌 III 期德国
-
Zydolab - Institute of Cytology and Immune CytochemistryRuhr University of Bochum完全的
-
Zydolab - Institute of Cytology and Immune CytochemistryRuhr University of Bochum完全的
-
Zydolab - Institute of Cytology and Immune CytochemistryRuhr University of Bochum完全的
-
Universität Duisburg-EssenEli Lilly and Company未知
-
AIO-Studien-gGmbHBristol-Myers Squibb完全的食道癌 | 胃食管癌 | 食道癌 | 胃食管癌 | 食管癌 NOS | 食管癌转移 | 食管癌转移 | 食管癌编号德国
-
AIO-Studien-gGmbHBoehringer Ingelheim终止
-
University Hospital FreiburgUniversity Hospital Heidelberg; Johannes Gutenberg University Mainz; Wako Diagnostics完全的
-
LMU KlinikumDepartment of Internal Medicine V, Thoracic Oncology Centre Munich, LMU Munich, Munich, Germany 和其他合作者招聘中肿瘤学 | 非小细胞肺癌,III 期 | 放化疗 | 生物标志物 | 度伐单抗德国
-
Ludwig-Maximilians - University of Munich招聘中
-
National Center for Tumor Diseases, HeidelbergPfizer; Roche Pharma AG终止
-
Institut für Klinische Krebsforschung IKF GmbH...Roche Pharma AG; Thoraxklinik-Heidelberg gGmbH招聘中
-
University Hospital HeidelbergDietmar Hopp Stiftung招聘中非小细胞肺癌 IIIB 期 | 非小细胞肺癌 II 期 | 非小细胞肺癌,IIIA 期德国
-
Charite University, Berlin, GermanyGerman Heart Institute完全的
-
German Breast GroupRoche Pharma AG; Celgene Corporation完全的炎性乳腺癌 | HER-2阳性乳腺癌 | 管状乳腺癌 II 期 | 粘液性乳腺癌 II 期 | 乳腺癌女性 NOS | 浸润性导管癌 | 管状乳腺癌 III 期 | 炎性乳腺癌 IV 期德国
-
University of LeipzigMedical University of Graz; University of Turku; University Medical Center Nijmegen未知
-
PD Dr. med. Wolfgang SchuetteEli Lilly and Company; Roche Pharma AG完全的
-
iOMEDICO AGNovartis完全的
-
Nykode Therapeutics ASATheradex; Vaccibody AS完全的